Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cassava Sciences
Biotech
Cassava pays $40M over allegedly misleading Alzheimer's update
The charges include the accusation that a former Cassava exec removed 40% of the participants from an analysis of the episodic memory results.
Nick Paul Taylor
Sep 27, 2024 9:20am
Cue Biopharma queues up J&J vet as CBO—Chutes & Ladders
Sep 13, 2024 8:30am
Chutes & Ladders—Gilead's Merdad Parsey goes, Cassava loses CEO
Jul 19, 2024 8:00am
Cassava hints 'short-sellers' to blame for leaking CUNY report
Oct 13, 2023 9:46am
Cassava claims win in open-label Alzheimer's study, shares fall
Jan 24, 2023 11:30am
Frazier departs Merck after 30 years—Chutes & Ladders
Oct 28, 2022 9:30am
